Pharmabiz
 

Bid to boost pharma exports to CIS nations

Our Bureau , MumbaiThursday, November 11, 2010, 08:00 Hrs  [IST]

In order to give a boost to the exports to Commonwealth Independent States (CIS),which has been growing at five per cent during the last five years, Pharmaceutical Exports Promotion Council (Pharmexcil) is planning to take more trade delegations to CIS nations according to a spokesperson of the council.

In the last three to four years, Pharmexcil has been taking a number of delegations to these countries covering almost all the CIS nations, he added

At the same time the government of India is in the process of designing bilateral business arrangements with countries like Russia and Kazakhstan and also talks with more countries in the CIS are under consideration to support the Indian pharma exporters to aggressively win the overseas market.

India and Russia are planning to sign a Memorandum of Understanding (MoU) for exploring the possibility of setting up of joint ventures in pharma and bio-pharma sectors, API and therapeutic specific sectors in both countries, including jointly setting up of R&D/testing facilities.

At a meeting between the visiting Russian delegation led by Russian minister for Industry and Trade, Victor B Khristenko and the senior officials of the Department of Pharmaceuticals led by secretary, Mukul Joshi recently, Russia also agreed to exchange of technical know-how for production of pharma products including bulk drugs, serums, biosimilars, vaccines etc, participation in setting up of enterprises for scientific and production capacity.

The two sides have also agreed on a draft MoU to encourage collaboration in the areas of trade, industry, joint ventures and R&D in the pharma and bio-pharma sectors. They have also agreed to exchange of information on the issues of regulation in the export/import of pharmaceuticals products including Active Pharmaceuticals Ingredients etc according to official sources.

During the meeting, the two sides discussed the issues relating to pharma and bio-pharma sectors including support to Indian joint ventures for government procurement from Russian side in terms of market assurance, tax and investment incentives, financial collaboration, infrastructure and utility services, protection of investment made by Indian industry, easy repatriation of profits and other incentives and specific support during construction/establishment of production facilities in Russia including work force from India etc.

In the meanwhile an agreement on Russia-India Biotech Network (RIBN) was recently signed in Andhra Pradesh in the the presence of Chief Minister K Rosaiah. The agreement was signed by Professor Raif Vasilov, President, Russian Biotechnology Society and Chief Executive Officer, Russian Bio-industry Association and Dr B S Bajaj, convener, BioAsia 2011 and secretary, Federation of Asian Biotech Associations (FABA). RIBN will be a dedicated on-line platform to effectively facilitate collaboration between the Russian and Indian biotech communities.

The interested Russian companies will be able to browse through the profile of their Indian counterparts and interact with them to understand their activities in detail and vice versa.

The Chief Minister also officially announced the eighth edition of BioAsia, the global bio-business forum, to be held from February 21-24, 2011 at India’s first bio-city, Hyderabad.

BioAsia 2011 will feature three tracks namely MediAsia, HealthAsia and AgriAsia. The event is expected to attract a wide range of entrepreneurs including senior executives of leading biotech companies, business development teams from large and mid-size pharma companies, eminent scientists from R&D institutions, universities, investors and other industry experts to explore global business tie-ups.

At the same time at a recent two day Indo-CIS Business Meet in Mumbai, officials from the Indian side had announced proactive steps like setting up warehousing facilities in pharma hubs in the CIS region and exploring bilateral agreements and reciprocal recognition of regulatory norms with concerned authorities in this region.

Addressing a business delegation from the CIS nations, in a business meet between the Indian pharma and the buyers from 15 CIS countries organised by Pharmexcil,Ashok Kumar, secretary, Department of Pharmaceuticals (DoP) said the Indian pharma industry is equipping itself with global standards in quality of manufacturing and products and the country, with its strength in generics, has huge opportunities to be explored in the CIS pharma market.

 
[Close]